|Articles|July 1, 2003

Santen seeks OK for concentrated antibiotic

Napa, CA-Santen Pharmaceutical Co. is hoping that its higher-concentration ocular antibiotic will set a new standard for treatment of bacterial corneal ulcers.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.


Latest CME